We observed in our model that IL-4 treatment robustly promoted microglia/macrophage polarization toward an anti-inflammatory phenotype (CD206+Iba1+) at 7 and 14 d after stroke (S4 Fig). The gene discussed is MRC1; the disease is stroke disorder.